BeOne Medicines AG (FRA:49BA)

BeOne Medicines AG Statistics

Total Valuation

FRA:49BA has a market cap or net worth of EUR 32.14 billion. The enterprise value is 29.55 billion.

Market Cap	32.14B
Enterprise Value	29.55B

Important Dates

The next estimated earnings date is Wednesday, April 15, 2026.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+6.60%
Shares Change (QoQ)	+1.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	68.16M

Valuation Ratios

The trailing PE ratio is 550.18 and the forward PE ratio is 63.66.

PE Ratio	550.18
Forward PE	63.66
PS Ratio	7.58
PB Ratio	9.13
P/TBV Ratio	9.28
P/FCF Ratio	69.25
P/OCF Ratio	48.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 99.95, with an EV/FCF ratio of 63.67.

EV / Earnings	505.79
EV / Sales	6.91
EV / EBITDA	99.95
EV / EBIT	210.17
EV / FCF	63.67

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.25.

Current Ratio	2.39
Quick Ratio	2.09
Debt / Equity	0.25
Debt / EBITDA	2.82
Debt / FCF	1.87
Interest Coverage	6.93

Financial Efficiency

Return on equity (ROE) is 1.81% and return on invested capital (ROIC) is 2.36%.

Return on Equity (ROE)	1.81%
Return on Assets (ROA)	1.69%
Return on Invested Capital (ROIC)	2.36%
Return on Capital Employed (ROCE)	3.45%
Revenue Per Employee	385,293
Profits Per Employee	5,311
Employee Count	11,000
Asset Turnover	0.74
Inventory Turnover	1.43

Taxes

In the past 12 months, FRA:49BA has paid 96.92 million in taxes.

Income Tax	96.92M
Effective Tax Rate	62.39%

Stock Price Statistics

The stock price has increased by +69.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+69.41%
50-Day Moving Average	280.16
200-Day Moving Average	251.81
Relative Strength Index (RSI)	60.21
Average Volume (20 Days)	16

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.56

Income Statement

In the last 12 months, FRA:49BA had revenue of EUR 4.24 billion and earned 58.43 million in profits. Earnings per share was 0.50.

Revenue	4.24B
Gross Profit	3.65B
Operating Income	155.00M
Pretax Income	155.34M
Net Income	58.43M
EBITDA	279.70M
EBIT	155.00M
Earnings Per Share (EPS)	0.50

Balance Sheet

The company has 3.44 billion in cash and 869.33 million in debt, with a net cash position of 2.57 billion.

Cash & Cash Equivalents	3.44B
Total Debt	869.33M
Net Cash	2.57B
Net Cash Per Share	n/a
Equity (Book Value)	3.52B
Book Value Per Share	31.81
Working Capital	2.81B

Cash Flow

In the last 12 months, operating cash flow was 669.39 million and capital expenditures -205.23 million, giving a free cash flow of 464.16 million.

Operating Cash Flow	669.39M
Capital Expenditures	-205.23M
Free Cash Flow	464.16M
FCF Per Share	n/a

Margins

Gross margin is 86.19%, with operating and profit margins of 3.66% and 1.38%.

Gross Margin	86.19%
Operating Margin	3.66%
Pretax Margin	3.67%
Profit Margin	1.38%
EBITDA Margin	6.60%
EBIT Margin	3.66%
FCF Margin	10.95%

Dividends & Yields

FRA:49BA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.60%
Shareholder Yield	-6.60%
Earnings Yield	0.18%
FCF Yield	1.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:49BA has an Altman Z-Score of 4.29 and a Piotroski F-Score of 8.

Altman Z-Score	4.29
Piotroski F-Score	8